VR506

DRUG2 trials

Sponsors

Vectura Limited

Conditions

Asthma

Phase 2

Clinical Study to Evaluate the Efficacy of VR506 Using a New Inhaler for the Treatment of Asthma

CompletedNCT01472757

Vectura LimitedAsthma

Start: 2011-10-31End: 2013-05-31Updated: 2020-04-21

Clinical Study to Evaluate the Efficacy and Safety of VR506 Using a New Inhaler for the Treatment of Asthma

CompletedNCT01720069

Vectura LimitedAsthma

Start: 2012-10-31End: 2013-10-31Updated: 2020-04-21